New implant aims to keep failing hearts in check
NCT ID NCT03375710
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 34 times
Summary
This study tested a new device called the Cordella Heart Failure System in 15 people with advanced heart failure (NYHA Class III). The device is implanted to measure pressure in the lung artery, helping doctors manage the condition. The goal was to see if the implant is safe and gives accurate readings compared to standard methods. This is not a cure, but a way to better control heart failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE NYHA CLASS III are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Galway University Hospital
Galway, H91 YR71, Ireland
-
Ziekenhuis Oost Limburg
Genk, 3600, Belgium
Conditions
Explore the condition pages connected to this study.